Dr. Suzuki is board certified in thoracic and general surgery, with clinical interest in robotic surgery and research interest in early detection and prognostication of lung cancer as well as socioeconomic disparity in the screening and treatment of lung cancer patients. Dr. Suzuki did his general surgery residency at Beth Israel Medical Center in New York. During his general surgery residency, he spent 2 years in the Adusumilli Lab at Memorial Sloan Kettering Cancer Center in New York, where he dedicated time investigating immune response in stage I lung adenocarcinoma. He then completed cardiothoracic surgery fellowship at Presbyterian/Memorial Sloan Kettering Cancer Center in New York. Upon graduating, he joined Boston Medical Center in 2017 and has been on faculty since.
Focused issue outline:
- Effect of smoking on immune response in lung
- Immune response in lung CA detection
- Immune response in suspicious lung nodules
- Immune response in the peripheral blood of stage I lung cancer
- Immune response in the tumor microenvironment of stage I lung cancer
- Lymphatic drainage in lung cancer
- Research advance in tumor specific antigens
- Pathologic assessment of immune/inflammatory response in lung cancer
The series “Immune Response in Lung Cancer” was commissioned by the editorial office, AME Medical Journal without any sponsorship or funding. Kei Suzuki is serving as the unpaid Guest Editors for the series.